Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Altman

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Dermatologic Clinics|May 3, 2000
The roles of the pharmaceutical industry and drug development in dermatology and dermatologic health careD J Altman
Journal of Clinical Neuromuscular Disease|December 17, 2008
Lepromatous neuropathyD J Altman, A Amato
Lancet (London, England)|April 19, 1986
Regression analysisJ M Bland, D J Altman
Journal of the American Academy of Dermatology|February 25, 2000
The combination of 2% 4-hydroxyanisole (Mequinol) and 0.01% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studiesA B Fleischer, E H Schwartzel, S I Colby, et al.
The Journal of Experimental Medicine|November 1, 1990
A transforming growth factor beta 2 (TGF-beta 2)-like immunosuppressive factor in amniotic fluid and localization of TGF-beta 2 mRNA in the pregnant uterusD J Altman, S L Schneider, D A Thompson, et al.
The Journal of Investigative Dermatology|May 1, 1996
Interleukin-15 mRNA is expressed by human keratinocytes Langerhans cells, and blood-derived dendritic cells and is downregulated by ultraviolet B radiationA Blauvelt, H Asada, V Klaus-Kovtun, et al.
The Journal of Clinical Investigation|October 23, 1997
Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathwaysA Blauvelt, H Asada, M W Saville, et al.
Journal of Drugs in Dermatology : JDD|July 11, 2003
A promising new treatment for solar lentiginesS I Colby, E H Schwartzel, F J Huber, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Dermatologic Clinics|May 3, 2000
The roles of the pharmaceutical industry and drug development in dermatology and dermatologic health careD J Altman
Journal of Clinical Neuromuscular Disease|December 17, 2008
Lepromatous neuropathyD J Altman, A Amato
Lancet (London, England)|April 19, 1986
Regression analysisJ M Bland, D J Altman
Journal of the American Academy of Dermatology|February 25, 2000
The combination of 2% 4-hydroxyanisole (Mequinol) and 0.01% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studiesA B Fleischer, E H Schwartzel, S I Colby, et al.
The Journal of Experimental Medicine|November 1, 1990
A transforming growth factor beta 2 (TGF-beta 2)-like immunosuppressive factor in amniotic fluid and localization of TGF-beta 2 mRNA in the pregnant uterusD J Altman, S L Schneider, D A Thompson, et al.
The Journal of Investigative Dermatology|May 1, 1996
Interleukin-15 mRNA is expressed by human keratinocytes Langerhans cells, and blood-derived dendritic cells and is downregulated by ultraviolet B radiationA Blauvelt, H Asada, V Klaus-Kovtun, et al.
The Journal of Clinical Investigation|October 23, 1997
Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathwaysA Blauvelt, H Asada, M W Saville, et al.
Journal of Drugs in Dermatology : JDD|July 11, 2003
A promising new treatment for solar lentiginesS I Colby, E H Schwartzel, F J Huber, et al.
Pageof 1